RA CAPITAL MANAGEMENT L.P. 13D and 13G filings for Travere Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-05-15 5:02 pm Sale | 2023-05-15 | 13G | Travere Therapeutics, Inc. TVTX | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -3,984,681 (Position Closed) | Filing |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | Travere Therapeutics, Inc. TVTX | RA CAPITAL MANAGEMENT L.P. | 3,984,681 6.200% | -1,629,747 (-29.03%) | Filing |
| 2022-02-14 4:11 pm Purchase | 2021-12-31 | 13G | Travere Therapeutics, Inc. TVTX | RA CAPITAL MANAGEMENT L.P. | 5,614,428 9.200% | 1,056,561 (+23.18%) | Filing |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | Travere Therapeutics, Inc. TVTX | RA CAPITAL MANAGEMENT L.P. | 4,557,867 8.900% | 4,557,867 (New Position) | Filing |